University of Strathclyde Researchers Secure £2.6M Grant to Develop Preclinical Lead Drug Candidate…
Researchers at the University of Strathclyde have been awarded £2.6 million to develop a preclinical lead drug candidate targeted at advanced prostate and colorectal cancers.
Both cancers are driven by inflammatory protein signalling –…